Amicus Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
29.09.23
/
50%
€11.70
Target price
29.09.24
€17.92
Performance (%)
-16.24%
Price
20.09.24
€9.70
This prediction will end soon
Summary
This prediction is currently active. The price of Amicus Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.24%. This prediction currently runs until 29.09.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -4.902% | -4.902% |
iShares Core DAX® | 0.347% | 2.173% |
iShares Nasdaq 100 | 0.715% | 0.138% |
iShares Nikkei 225® | 1.522% | 2.003% |
iShares S&P 500 | 0.631% | 1.633% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $17.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.40
16.08.24
16.08.24
€14.55
16.08.25
16.08.25
-5.77%
20.09.24
20.09.24